Toxicity Associated with Immune Checkpoint Inhibitors: Analysis of Immune-Related Adverse Events with a Pembrolizumab Biosimilar (Pembroria)

Toxicity Associated with Immune Checkpoint Inhibitors: Analysis of Immune-Related Adverse Events with a Pembrolizumab Biosimilar (Pembroria)

In recent years, there has been a significant increase in the number of patients with malignancies treated with immune checkpoint inhibitors (ICIs), including the anti-programmed cell death protein 1 (anti-PD-1) agent pembrolizumab. One of the important aspects of conducting clinical trials with ICI...

Full description

Saved in:
Bibliographic Details
Main Authors: M. Yu. Fedyanin (Author), A. V. Snegovoy (Author), V. V. Breder (Author), Yu. N. Linkova (Author), A. V. Zinkina-Orikhan (Author), S. B. Setkina (Author), S. N. Fogt (Author), V. S. Chistiakov (Author), N. A. Kravtsova (Author)
Format: Book
Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2023-06-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items